Supporting Medical Research Since 1963
History
The Lions Medical Research Foundation has a long and successful history. It began as an idea put forward at a Lions Convention in 1963. A Lions member, Mr Arthur Midsen, who at the time was a member of the Board of the Princess Alexandra Hospital, successfully moved a motion at the convention that "Lions resolve to establish a laboratory at the Princess Alexandra Hospital, Brisbane, Australia, in which to conduct research into kidney disease". Forty Lions clubs supported the project with yearly contributions over a minimum of three years to provide the necessary funding.
1960's to 1990's
1963
A group of Lions Members, Mr John Henley, Mr Rae Strain, Mr Robert Allen and Mr Ray Phippard, discussed at a Lions Convention the need to fund research into kidney disease. Lions Club members embraced this idea and later expanded this funding into other medical areas.
1966
The Lions Renal Research Laboratory began operations at the Princess Alexandra Hospital, Brisbane Qld.
1966
Dr John Healy was the Foundation's first recipient of funding for research. Dr Healy was working at Georgetown University Hospital in Washington DC, USA, but returned to Australia to become the first Lion's Research Fellow at the Princess Alexandra Hospital, Brisbane. By 1978, Dr Healy had won world acclaim by publishing nineteen articles and developing the kidney function test which became widely accepted.
1973
A decision was made to name the Foundation the 'Lions Kidney and Medical Research Foundation'.
1975
Memorandum of Association and Articles of Association approved by Lions Clubs International and the Queensland State Government.
1977
The Foundation established a research centre at the Princess Alexandra Hospital.
1978
Prof. Brian Emmerson recommended the Foundation support Immunology research.
Lions Kidney & Medical Research provided $1.2 million towards building the Research Centre at the Princess Alexandra Hospital, Brisbane Qld.
Dr Don Cameron, Endocrinology. Research into possibility of insulin orally to a diabetic. Dr Cameron was an LMRF fellow from 1978 to 1980.
Dr J Armstrong & Dr C Mitchell, Asthma research. Dr Armstrong and Dr Mitchell were LMRF fellows from 1978 to 1980.
Dr Michael Robinson, Immunology and tissue matching research PA. Dr Robinson was an LMRF fellow from 1978 to 1983.
Dr Owen Harris, Gastroenterology research including pancreatic testing. Dr Harris was an LMRF fellow from 1978 to 1982.
Dr P Ravenscroft & Dr D Pritchard, Disopyramide by injection for heart attack treatments and acute Myocardial infaction research. Dr Ravenscroft and Dr Pritchard were LMRF fellows from 1978 to 1981.
Dr R Cartmill, Urodynamics including urine retention and incontinence. Dr Cartmill was an LMRF fellow from 1978 to 1981.
1981
Dr John Ohlrich, Ophthalmology research. Dr Ohlrich was an LMRF fellow from 1981 to 1982.
1983
Lions Professor Lawrence Hirst, Ophthalmology received $250,000 to outfit his area of research which led to the Queensland Eye Bank storing corneas prior to transplantation. Prof Hirst was an LMRF fellow from 1983 to 1984 and again in 1986 to 1991 and 1995 to 1999.
1984
Associate Professor Alan Whittaker, King Brown snake anti-coagulant research. Assoc. Prof Whittaker was an LMRF fellow from 1984 to 1990.
1985
Professor Susan Pond, Pharmacology (Paraquat poisoning) research into medical drugs. Prof Pond was an LMRF fellow from 1985 to 1994 and again in 1995 to 1997.
Dr Robert Tindle, Immunology research into Human Papillomavirus Infections (HPV). Dr Tindle now has an international reputation in the field of HPV. Dr Tindle was an LMRF fellow from 1985 to 1986 and again in 1991 to 1992.
1986
A bright new molecular biologist, Dr Ian Frazer, was funded by the Foundation to research 4h drugs used in the treatment of AIDS. Dr Frazer was about to return to Scotland, but with this funding was able to move from Melbourne to Brisbane to continue his research. Dr Frazer also had ideas on how immunology might provide a vaccine to prevent cervical cancer. The now Professor Ian Frazer went on to a world first in the invention of the Cervical Cancer vaccine Gardasil and became the CEO of the Translational Research Institute which opened in 2013.
The completion and opening of the Lions Kidney & Medical Research Building at the Princess Alexandra Hospital, Brisbane Qld.
1987
Dr Harvey Whiteford, Biological Psychiatry; the funding led Dr Whiteford to establishing the Queensland Centre for Mental Health Research. Now Professor Whiteford has an international reputation in mental health policy and held the first mental health position with the World Bank. Prof Whiteford is now the Kratzmann Prof. of Psychiatry & Population Health at The University of Queensland and Director of Policy & Evaluation at the Queensland Centre for Mental Health Research of which he was instrumental in forming. Prof Whiteford was an LMRF fellow from 1987 to 1990.
1990
Professor Michael Roberts, appointed Lions Professional Research Fellow in Clinical Pharmacology and Toxicology. Prof Roberts was an LMRF fellow from 1990 to 1992.
1991
Professor Paul Colditz was appointed Lions Research Fellow at the Perinatal Research Centre at the Royal Brisbane & Women's Hospital. Prof Colditz is now the Director of the Perinatal Research Centre. Prof Colditz researched into brain development, hypoxic damage in brains and kidney, ensuring that mothers and babies receive the optimal evidence-based investigations and treatments. Prof Colditz was an LMRF fellow from 1991 to 1998.
Dr George Mellick, trained in chemistry and biochemistry and was awarded a Lions Postgraduate Scholarship towards the completion of his PhD in medicine. Dr Mellick worked in the Centre for Genomics & Bioinformatics in Sweden, returned to Australia lecturing in School of Medicine UQ. He researches neuro-degenerative diseases such as Parkinson's Disease within Griffith University. Dr Mellick was an LMRF fellow from 1991 to 1993.
1992
Dr John Ambler, Ophthalmology in vitreo-retinal diseases. Dr Ambler was an LMRF fellow from 1992 to 1993.
Dr Ross Gordon, Pharmacology and Toxicology production of single-chain antibodies. Dr Gordon was an LMRF fellow from 1992 to 1994.
1993
Professor Frank Gardner, Urology research into prostate cancer. Prof Gardener was an LMRF fellow from 1993 to 1994.
Dr John McGrath, research into schizophrenia, genetic and non-genetic causes. He is Queensland's Centre for Medical Health Research Director, Developmental Neurobiology and Epidemiology. Dr McGrath won the Premier's Award for Medical Research in 2002 and in 2003 was awarded a Queensland Smithsonian Fellowship. Dr McGrath was an LMRF fellow from 1993 to 1996.
1995
Dr Kathy Avent, Pharmacology and Toxicology research. Dr Avent was an LMRF fellow from 1995 to 1996.
Dr Hayley R Inglis, Immunology research into autoimmune encephalomyelitis. Dr Inglis was an LMRF fellow from 1995 to 1996.
Dr Kirsty James and Dr Sally McCann. Dr James and Dr McCann were LMRF fellows from 1995 to 1996.
1996
Dr Daniel Hung, Pharmacology and Toxicology research. Dr Hung and Dr Lai were LMRF fellows from 1996 to 1998.
Dr Pam Lai, Pharmacology and Toxicology research. Dr Hung and Dr Lai were LMRF fellows from 1996 to 1998.
Dr Karen Milne. Dr Milne was an LMRF fellow from 1996 to 1997.
1997
In order to incorporate the research being undertaken by Lions Medical Research, the name 'Lions Kidney & Medical Research Foundation' was changed to 'The Queensland & Northern New South Wales Lions Medical Research Foundation'.
Associate Professor Yuri Annissimov, Biomolecular research. Assoc. Prof Annissimov was an LMRF fellow from 1997 to 1999.
Dr Carol Browne, Perinatal Asphyxia research into perinatal care. Dr Browne was an LMRF fellow from 1997 to 2000.
1998
Dr Kelly Foster Perinatal Asphyxia research into perinatal care. Dr Foster was an LMRF fellow from 1997 to 2002.
Dr Paul Lovelock, a molecular biologist researching better treatments for Diabetes Type 2. Dr Lovelock was an LMRF fellow from 1998 to 2002.
Dr Nick Saunders, Squamous Cell Carcinomas research. Dr Saunders received $250,000 for studies into the development of Novel Skin Cancer Therapies. Dr Saunders was an LMRF fellow from 1998 to 2004.
1999
Dr Robyn Rodwell, Cord blood and Molecular genetic screening receiving $300,000. Dr Rodwell was an LMRF fellow from 1999 to 2003.
2000's and Current Researchers
2000
Dr Peter Madden, Ophthalmology and the development of in-vitro corneal transplant material. Initial examination of Australian made media to allow organ culture of corneas and thereby extend storage from the current 7 days to 30 days. Dr Madden wan as LMRF fellow from 2000 to 2007.
Dr Glen Ulett, Melioidosis research receiving $25,000 to research mosquito born diseases. Dr Ulett was an LMRF fellow from 2000 to 2001.
2001
Dr Jonathan Whitehead, Research into insulin resistance in Type 2 Diabetes and links with obesity. Dr Whitehead was an LMRF fellow from 2001 to 2007.
2002
The commissioning of the second floor of the new research building after the demolition of the Lions Building within the Princess Alexandra Hospital.
Memorandum of Understanding between the Diamantina Institute for Cancer, Immunology and Metabolic Medicine and the Foundation was signed.
Dr Jonathan Golledge, James Cook University. Role of diabetes mellitus in artery complications. Work is targeted at development of a medical treatment for aortic aneurysm. Improve understanding of factors involved in the weakening and abnormal dilation of the main abdominal artery. Dr Gollegde was an LMRF fellow from 2002 to 2005.
Dr Julie Jonsson, research to find out how fatty liver increases fibrosis (Rennin ANG10 tensin system in kepatic fibrosis). Dr Jonsson hoped by defining the mechanisms responsible, she could identify possible therapeutic targets for drug development to treat chronic liver disease. Dr Jonsson was an LMRF fellow from 2002 to 2006.
2004
Dr Graham Leggatt, Vaccine investigation into killer T cells biology so that improvements can be made in the next generation of vaccines targeting tumours and viral infections such as HIV. Dr Leggatt was an LMRF fellow from 2004 to 2007.
Dr Corey Moran, James Cook University. Research into the dangers of arteries rupturing in men over 60 years. Dr Moran was an LMRF fellow from 2004 to 2005.
2005
Dr Heather Beamish, Cancer cell cycles targeting cell cycle check points to treat cancer and improve treatments involving the identification of mutations in cancer cells and specifically targeting those mutations. Dr Beamish was an LMRF fellow from 2005 to 2008.
2006
Dr Kathryn Buller, Perinatal research determining mechanisms contributing to brain injury in premature neonates due to reduced oxygen and blood flows to the brain. Dr Buller was an LMRF fellow from 2006 to 2010.
2007
Dr Christine Staatz, Pharmacology research tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplants. Dr Staatz was an LMRF fellow from 2007 to 2011.
Dr Gethin Thomas, Osteoporosis research, identification and characterisation of novel genes involved in bone and joint disease, specifically a form of arthritis affecting the spine called ankylosing spondylitis and osteoporosis. This increased knowledge of the disease processes can then give rise to new drugs and treatments. Dr Thomas was an LMRF fellow from 2007 to 2011.
2008
Dr Ingrid Hickman, Obesity related inflammation and insulin resistance in chronic Liver disease. Exercise and diet as treatment options. Dr Hickman was an LMRF fellow from 2008 to 2012.
2009
Dr Katrina Campbell, Nutrition-related mediators of cardiovascular disease progression in chronic kidney disease (CKD). Many risk factors for both cardiovascular disease and kidney disease progression, including high blood pressure, vascular stiffness, fluid overload, urinary protein and inflammation are linked to dietary intake. This research aims to identify the relationship between diet and heart health in patients with kidney disease. In addition, this research aims to test the effect of a low salt diet, and other dietary interventions on kidney and heart health. Dr Campbell was an LMRF from 2009 to 2012.
2011
Dr (Stella) Tracey Bjorkman, Perinatal GABA receptive development researching hypoxic injury in newborns; seizures and brain injuries and neuroprotective therapies. Dr Bjorkman was an LMRF fellow from 2011 to 2018.
2012
Dr Nadeeka Dissanayaka, researching anxiety and depression in Parkinson's disease sufferers. Dr Dissanayaka was an LMRF fellow from 2012 to 2019.
2013
Commencement of the SPARQ-ed program, Translational Research Institute.
2016
Dr Carlos Salomon, Ovarian Cancer research to better understand the origins and causes of Ovarian Cancer, and screening and prevention by altering the profiles of exosomes. Dr Salomon is now an Associate Professor and was LMRF fellow from 2016 to 2022.
2019
Dr Olivia Holland, research into diabetes during pregnancy, and in the underlying mechanisms that link placental dysfunction to pregnancy complications and the later development of conditions such as obesity and type 2 diabetes in adulthood. Dr Holland is a current LMRF fellow from 2019.
2022
Dr Dominic Guanzon, Ovarian Cancer research and development of a diagnostic test to predict the recurrence of Ovarian Cancer and whether it is resistant to cancer drugs (chemoresistance). Dr Guanzon is a current LMRF fellow from 2022.
There are many successful medical researchers who have received funding through the Foundation. Today, the Foundation has supported medical research at the University of Queensland Centre for Clinical Research, the Princess Alexandra Hospital, Institute of Health and Biomedical Innovation, Queensland University of Technology, and the School of Medical Science, Griffith University.
Other notable recipients are Professor Ian Frazer who received early funding for his world-famous research into cervical cancer and the development of Gardasil, Professor Lawrie Hirst's ground-breaking Optical research which led to the Queensland Eye Bank for storage of corneal, Professor Paul Colditz' Perinatal research into preterm babies and Dr Kathryn Buller's research which examined brain injury in neonates plus many other worthy researchers.
The Queensland and Northern New South Wales Lions Medical Research Foundation is committed to start-up funding for world class medical research.
Research is tomorrow's hope.